R. Eshet

744 total citations
25 papers, 579 citations indexed

About

R. Eshet is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Genetics. According to data from OpenAlex, R. Eshet has authored 25 papers receiving a total of 579 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Physiology and 7 papers in Genetics. Recurrent topics in R. Eshet's work include Growth Hormone and Insulin-like Growth Factors (20 papers), Diet and metabolism studies (6 papers) and Cancer, Hypoxia, and Metabolism (4 papers). R. Eshet is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (20 papers), Diet and metabolism studies (6 papers) and Cancer, Hypoxia, and Metabolism (4 papers). R. Eshet collaborates with scholars based in Israel and United States. R. Eshet's co-authors include Zvi Laron, Zvi Laron, Ruth Arnon, A Pertzelan, A. Silbergeld, B. Klinger, Moshe Phillip, Gila Maor, Galia Gat‐Yablonski and Yael Segev and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Endocrinology and Clinica Chimica Acta.

In The Last Decade

R. Eshet

25 papers receiving 567 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Eshet Israel 14 416 187 175 101 78 25 579
Catherine A. Lissett United Kingdom 13 435 1.0× 94 0.5× 109 0.6× 109 1.1× 34 0.4× 18 524
J. S. Christiansen Denmark 15 431 1.0× 108 0.6× 83 0.5× 134 1.3× 126 1.6× 29 568
Don Fleenor United States 9 242 0.6× 133 0.7× 124 0.7× 125 1.2× 179 2.3× 10 528
Rossana M. C. Pereira Brazil 17 485 1.2× 93 0.5× 168 1.0× 156 1.5× 81 1.0× 24 617
C. M. Hall United Kingdom 12 209 0.5× 177 0.9× 121 0.7× 82 0.8× 71 0.9× 14 490
Arved Roovete Sweden 9 340 0.8× 199 1.1× 78 0.4× 109 1.1× 154 2.0× 10 574
E Bartolotta Italy 9 349 0.8× 121 0.6× 120 0.7× 77 0.8× 69 0.9× 22 441
AMILTON C. S. FARIA United States 7 514 1.2× 126 0.7× 70 0.4× 137 1.4× 72 0.9× 7 581
Camilla A M Glad Sweden 15 345 0.8× 197 1.1× 105 0.6× 237 2.3× 88 1.1× 27 691
Anne Gill United States 10 293 0.7× 221 1.2× 109 0.6× 117 1.2× 87 1.1× 14 708

Countries citing papers authored by R. Eshet

Since Specialization
Citations

This map shows the geographic impact of R. Eshet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Eshet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Eshet more than expected).

Fields of papers citing papers by R. Eshet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Eshet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Eshet. The network helps show where R. Eshet may publish in the future.

Co-authorship network of co-authors of R. Eshet

This figure shows the co-authorship network connecting the top 25 collaborators of R. Eshet. A scholar is included among the top collaborators of R. Eshet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Eshet. R. Eshet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eshet, R., et al.. (2004). The aromatase inhibitor letrozole increases epiphyseal growth plate height and tibial length in peripubertal male mice. Journal of Endocrinology. 182(1). 165–172. 31 indexed citations
2.
3.
Gil‐Ad, Irit, Biana Shtaif, R. Eshet, et al.. (2001). Effect of dehydroepiandrosterone and its sulfate metabolite on neuronal cell viability in culture.. PubMed. 3(9). 639–43. 15 indexed citations
4.
5.
Eshet, R., A. Silbergeld, Rina Zaizov, et al.. (2000). DECREASED INSULIN-LIKE GROWTH FACTOR-I RECEPTOR SITES ON CIRCULATING MONONUCLEAR CELLS FROM CHILDREN WITH ACUTE LEUKEMIA. Pediatric Hematology and Oncology. 17(3). 253–260. 7 indexed citations
6.
Landau, Daniel, Yael Segev, R. Eshet, Allan Flyvbjerg, & Moshe Phillip. (1999). Changes in the Growth Hormone‐IGF‐I Axis in Non‐obese Diabetic Mice. Journal of Diabetes Research. 1(1). 9–18. 20 indexed citations
7.
Diamant, Yoram Z., et al.. (1997). Increased number of IGF‐I receptors on erythrocytes of women with polycystic ovarian syndrome. Clinical Endocrinology. 47(2). 185–190. 9 indexed citations
8.
Silbergeld, A., Florence Dastot, B. Klinger, et al.. (1997). Intronic Mutation in the Growth Hormone (GH) Receptor Gene from a Girl with Laron Syndrome and Extremely High Serum GH Binding Protein: Extended Phenotypic Study in a Very Large Pedigree. Journal of Pediatric Endocrinology and Metabolism. 10(3). 265–74. 40 indexed citations
9.
Toren, Paz, Sofia Eldar, Nathaniel Laor, et al.. (1997). Lack of Effect of Methylphenidate on Serum Growth Hormone (GH), GH-Binding Protein, and Insulin-like Growth Factor I. Clinical Neuropharmacology. 20(3). 264–269. 17 indexed citations
10.
Yakar, Shoshana, Horacio M. Domené, Rina Meidan, et al.. (1994). Growth Hormone (GH) Stimulates Insulin-Like Growth Factor-I (IGF-I) and IGF-Binding Protein (IGFBP)-2 Gene Expression in Spleens of Juvenile Rats. Hormone and Metabolic Research. 26(8). 363–366. 10 indexed citations
11.
Domené, Horacio M., Z. Shen‐Orr, R. Eshet, et al.. (1994). Effect of GH status on renal insulin-like growth factor I (IGF-I), IGF-I receptor, IGF-binding protein (IGFBP) and GH receptor mRNA levels in prepubertal rats. 2(7). 611–616. 1 indexed citations
12.
Eshet, R., Haim Werner, B. Klinger, et al.. (1993). Up-regulation of insulin-like growth factor-I (IGF-I) receptor gene expression in patients with reduced serum IGF-I levels. Journal of Molecular Endocrinology. 10(2). 115–120. 39 indexed citations
13.
Eshet, R., B. Klinger, A. Silbergeld, & Zvi Laron. (1993). Modulation of IGF‐I receptors by exogenous hGH treatment in constitutionally short children. Clinical Endocrinology. 39(6). 687–693. 3 indexed citations
14.
Eshet, R., B. Klinger, A. Silbergeld, & Zvi Laron. (1993). Modulation of insulin like growth factor I (IGF-I) binding sites on erythrocytes by IGF-I treatment in patients with Laron syndrome (LS). Regulatory Peptides. 48(1-2). 233–239. 6 indexed citations
15.
Laron, Zvi, B. Klinger, R. Eshet, et al.. (1993). Laron syndrome due to a post-receptor defect: response to IGF-I treatment.. PubMed. 29(12). 757–63. 33 indexed citations
16.
Eshet, R., et al.. (1991). Erythrocytes from patients with low serum concentrations of IGF-I have an increase in receptor sites for IGF-I. European Journal of Endocrinology. 125(4). 354–358. 15 indexed citations
17.
Eshet, R., Sagit Peleg, Ζ. Josefsberg, et al.. (1985). Some Properties of the Plasma hGH Activity in Patients with Laron-Type Dwarfism Determined by a Radioreceptor Assay Using Human Liver Tissue. Hormone Research. 22(4). 276–283. 13 indexed citations
18.
Eshet, R., et al.. (1984). Defect of human growth hormone receptors in the liver of two patients with Laron-type dwarfism.. PubMed. 20(1). 8–11. 119 indexed citations
19.
Eshet, R., et al.. (1984). Direct visualization of binding, aggregation and internalization of human growth hormone in cultured human lymphocytes. European Journal of Endocrinology. 107(1). 9–15. 15 indexed citations
20.
Eshet, R., Zvi Laron, Melissa A. Brown, & Ruth Arnon. (1973). Imnmnoreactive Properties of the Plasma hGH from Patients with the Syndrome of Familial Dwarfism and High Plasma IR-hGH. The Journal of Clinical Endocrinology & Metabolism. 37(5). 819–821. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Catherine A. Lissett Breakdown of academic impact, for papers by J. S. Christiansen Breakdown of academic impact, for papers by Don Fleenor Breakdown of academic impact, for papers by Rossana M. C. Pereira Breakdown of academic impact, for papers by C. M. Hall Breakdown of academic impact, for papers by Arved Roovete Breakdown of academic impact, for papers by E Bartolotta Breakdown of academic impact, for papers by AMILTON C. S. FARIA Breakdown of academic impact, for papers by Camilla A M Glad Breakdown of academic impact, for papers by Anne Gill
Rankless by CCL
2026